Press release
Bronchitis Therapeutics Market Size Report 2032: Emerging Therapies and Future Growth Opportunities
Bronchitis Therapeutics Market Size
Discover Key Insights into the Bronchitis Market with DelveInsight's In-Depth Report @ Bronchitis Market Size- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Bronchitis Market Report
• In February 2025:- Chiesi Farmaceutici S.p.A:- A 52-week, Randomized, Double-blind, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500μg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.
• In February 2025:- Deciphera Pharmaceuticals Inc.:- The purpose of this study is to determine if vimseltinib is safe, tolerable and works effectively to treat adults with active moderate to severe cGVHD. Participants will be treated with vimseltinib in 28-day treatment cycles for approximately 2 years.
• In the 7MM, there were 19,517,000 cases of acute bronchitis in children and 29,174,000 cases in adults in 2022. During the predicted period, these cases are expected to rise
• Out of all the 7MM countries, Japan accounted for the least number of cases of chronic bronchitis, which formed ~4% of the total cases of chronic bronchitis in the 7MM
• In Germany, there were 1,574,000 cases of acute bronchitis in children and 2,819,000 cases in adults in 2022, respectively. During the predicted period, it is expected that these cases will rise
• In the 7MM in 2022, there were determined to be 26,954,000 instances of chronic bronchitis. By 2032, these cases are anticipated to rise
• Among the EU4, the UK, and France, acute bronchitis cases overall were found to be the highest. In 2022, these cases accounted for 47% of all cases of acute bronchitis in the EU4 and the UK
• Bronchitis Companies such as Hanlim Pharm. Co., Ltd, Ahn-Gook Pharmaceuticals Co.,Ltd, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm. Inc., Hyundai Pharmaceutical Co., LTD., Ahn-Gook Pharma, Bayer, Wake Forest University, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, and others
• Bronchitis Therapies such as HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox (Moxifloxacin, BAY12-8039), Oral N-acetycystein (NAC), Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8, and others
Stay ahead in the Bronchitis Therapeutics Market with DelveInsight's Strategic Report @ Bronchitis Market Outlook- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Epidemiology Segmentation in the 7MM
• Total Prevalence of Bronchitis
• Prevalent Cases of Bronchitis by severity
• Gender-specific Prevalence of Bronchitis
• Diagnosed Cases of Episodic and Chronic Bronchitis
Download the report to understand which factors are driving Bronchitis epidemiology trends @ Bronchitis Prevalence- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bronchitis market or expected to get launched during the study period. The analysis covers Bronchitis market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
Bronchitis Therapies and Companies
• HL301: Hanlim Pharm. Co., Ltd
• AGS: Ahn-Gook Pharmaceuticals Co.,Ltd
• N02RS1: PharmaKing
• levofloxacin: Johnson & Johnson
• YHD001: Yuhan Corporation
• KALOMINTM: Korea United Pharm. Inc.
• Acebrophylline: Hyundai Pharmaceutical Co., LTD.
• Synatura®: Ahn-Gook Pharma
• Avelox (Moxifloxacin, BAY12-8039): Bayer
• Oral N-acetycystein (NAC): Wake Forest University
• Moxifloxacin: Pfizer
• telithromycin: Sanofi
• TPI 1020: Pharmaxis
• Emeramide: EmeraMed
• ABX-IL8: Abgenix
Get In-Depth Knowledge on Bronchitis Market Trends and Forecasts with DelveInsight @ Bronchitis Treatment Market- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Bronchitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM
• Bronchitis Companies: Hanlim Pharm. Co., Ltd, Ahn-Gook Pharmaceuticals Co.,Ltd, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm. Inc., Hyundai Pharmaceutical Co., LTD., Ahn-Gook Pharma, Bayer, Wake Forest University, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, and others
• Bronchitis Therapies: HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox (Moxifloxacin, BAY12-8039), Oral N-acetycystein (NAC), Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8, and others
• Bronchitis Therapeutic Assessment: Bronchitis current marketed and Bronchitis emerging therapies
• Bronchitis Market Dynamics: Bronchitis market drivers and Bronchitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Bronchitis Unmet Needs, KOL's views, Analyst's views, Bronchitis Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Bronchitis Market Report @ Bronchitis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Bronchitis Market Report Introduction
2. Executive Summary for Bronchitis
3. SWOT analysis of Bronchitis
4. Bronchitis Patient Share (%) Overview at a Glance
5. Bronchitis Market Overview at a Glance
6. Bronchitis Disease Background and Overview
7. Bronchitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Bronchitis
9. Bronchitis Current Treatment and Medical Practices
10. Bronchitis Unmet Needs
11. Bronchitis Emerging Therapies
12. Bronchitis Market Outlook
13. Country-Wise Bronchitis Market Analysis (2019-2032)
14. Bronchitis Market Access and Reimbursement of Therapies
15. Bronchitis Market Drivers
16. Bronchitis Market Barriers
17. Bronchitis Appendix
18. Bronchitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchitis Therapeutics Market Size Report 2032: Emerging Therapies and Future Growth Opportunities here
News-ID: 4110773 • Views: …
More Releases from DelveInsight Business Research LLP
Mobile Clinics Market Forecast Report 2032: Size, Share, and Strategic Insights …
DelveInsight's Mobile Clinics Market Insights Report 2032 provides the current and forecast market analysis, individual leading Mobile Clinics Companies market shares, challenges, Mobile Clinics Market Drivers, barriers, trends, and key market Mobile Clinics companies in the market.
To read more about the latest highlights related to the Mobile Clinics Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/Mobile-Clinics-Market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Mobile Clinics Market…
Vein Illumination Devices Market Outlook Report 2032: Current Scenario, Growth O …
DelveInsight's Vein Illumination Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Vein Illumination Devices Companies market shares, challenges, Vein Illumination Devices Market Drivers, barriers, trends, and key market Vein Illumination Devices companies in the market.
To read more about the latest highlights related to the Vein Illumination Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Bioanalytical Testing Services Market Forecast Report 2032: Size, Share, and Str …
DelveInsight's Bioanalytical Testing Services Market Insights Report 2032 provides the current and forecast market analysis, individual leading Bioanalytical Testing Services Companies market shares, challenges, Bioanalytical Testing Services Market Drivers, barriers, trends, and key market Bioanalytical Testing Services companies in the market.
To read more about the latest highlights related to the Bioanalytical Testing Services Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/bioanalytical-testing-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Thyroid Gland Disorder Treatment Market Forecast Report 2032 by DelveInsight: Si …
DelveInsight's Thyroid Gland Disorder Treatment Market Insights Report 2032 provides the current and forecast market analysis, individual leading Thyroid Gland Disorder Treatment Companies market shares, challenges, Thyroid Gland Disorder Treatment Market Drivers, barriers, trends, and key market Thyroid Gland Disorder Treatment companies in the market.
To read more about the latest highlights related to the Thyroid Gland Disorder Treatment Market, get a snapshot of the key highlights entailed in the Market…
More Releases for Bronchitis
Rising Respiratory Disease Incidence Sparks Robust Growth In Bronchitis Treatmen …
The Bronchitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bronchitis Treatment Market?
The market for bronchitis treatments has seen robust expansion in the past few years, with projections showing an increase from $5.61 billion in 2024 to…
Acute Bronchitis Treatment Market: An In-Depth Analysis
The global Acute Bronchitis Treatment market was valued at approximately USD 6.3 billion in 2023 and is projected to reach around USD 9.9 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period.
Acute Bronchitis Treatment Market Overview
Acute bronchitis is a common respiratory condition characterized by inflammation of the bronchial tubes, leading to symptoms such as coughing and mucus production. The market's growth…
Bronchitis Treatment Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Bronchitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Bronchitis Treatment Market Outlook, Insights, Size 2024-2033
The bronchitis treatment market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising air pollution levels, cigarette smoking epidemic, increased respiratory infections, environmental and occupational exposures, lifestyle factors..
The bronchitis treatment market size is expected to see strong…
Acute Bronchitis Treatment Market: What are the key opportunities?
The report attempts to offer high-quality and accurate analysis of the global Acute Bronchitis Treatment Market, keeping in view market forecasts, competitive intelligence, and technological risks and advancements, and other important subjects. Its carefully crafted market intelligence allows market participants to understand the most significant developments in the global Acute Bronchitis Treatment market that are impacting their business. Readers can become aware of crucial opportunities available in the global Acute…
Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are…
